A detailed history of Livelsberger Financial Advisory transactions in Embecta Corp. stock. As of the latest transaction made, Livelsberger Financial Advisory holds 22 shares of EMBC stock, worth $323. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$323
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$11.46 - $16.56 $252 - $364
22 New
22 $310,000
Q4 2023

Mar 22, 2024

BUY
$12.87 - $19.09 $283 - $419
22 New
22 $416,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $850M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Livelsberger Financial Advisory Portfolio

Follow Livelsberger Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livelsberger Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Livelsberger Financial Advisory with notifications on news.